HedgeMountain

MPM BioImpact Innovations Equities Fund, LTD.

Grand Cayman, Cayman Islands · CIK 2028861
EmergingOffshore

MPM BioImpact Innovations Equities Fund, LTD. is a hedge fund based in Grand Cayman, Cayman Islands. According to its most recent Form D, filed Jun 26, 2026, the fund has sold $407,242 of interests to 1 investor since its first sale in Jun 2024. The minimum investment it accepts from an outside investor is $1,000,000. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Based on its first sale date and the amount raised, HedgeMountain classifies it as an emerging manager. Related persons named in the filing include Alan Kelly; Brendan Furey; Nicole Ramroop.

Performance

No verified returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to HedgeMountain directly.

Is this your fund? Report your monthly returns · How performance works

Total raised
$407,242Cumulative sales reported on Form D
Investors
1
First sale
Jun 3, 2024
Minimum investment
$1,000,000
Who can invest
Qualified purchasersSection 3(c)(7): generally $5M+ in investments
Offering exemption
Rule 506(b)No general advertising
Key people and entities
Alan Kelly; Brendan Furey; Nicole Ramroop
Latest Form D
Jun 26, 2026

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and HedgeMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures

Size compared with every hedge fund

Raised more than 11% of the 2,343 hedge funds based in Cayman Islands, and more than 3% of all 10,157 that report sales.

Other funds with the same team

More hedge funds in Grand Cayman